Deciphera Pharmaceuticals, Inc.: Piper Sandler is Neutral







Marketzone with MT Newswires 2022

All the news about DECIPHERA PHARMACEUTICALS, INC.

Analyst Recommendations for DECIPHERA PHARMACEUTICALS, INC.

2022 turnover 124M
–
121M
2022 net result -180M
–
-176M
trso. net 2022 357M
–
349M
PER 2022-6.37x
2022 return–
Capitalization 1,151M
1,151M
1,125M
VE / CA 20226.41x
VE / CA 20235.73x
Number of employees280
Floating72.1%

Chart DECIPHERA PHARMACEUTICALS, INC.


Hard :

Period:




Deciphera Pharmaceuticals, Inc. : Deciphera Pharmaceuticals, Inc. Technical Analysis Chart | Market area

Trending Technical Analysis DECIPHERA PHARMACEUTICALS, INC.

Short termMiddle termLong term
TrendsbullishbullishNeutral

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts9
Last Closing Price$16.81
Average price target$11.43
Deviation / Average Target-32.0%

Officers and Directors




Source link -88